Oral: 150–450 mg every 6 hours, Endocarditis prophylaxis: 600 mg 1 hour before procedureIV/IM: 0.6–4.8 g daily in 2–4 divided doses,Prophylaxis: 300 mg 15 minutes before procedure then 150 mg 6 hours later
20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function. See ‘Other Information’
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function
HD                     :Not dialysed. Dose as in normal renal function
HDF/high flux   :Unknown dialysability. Dose as in normal renal function
CAV/VVHD      :Not dialysed. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsCiclosporin: may cause reduced ciclosporin levelsErythromycin: antagonism demonstrated in vitro; manufacturers recommend that the two drugs should not be administered concurrentlyMuscle relaxants: enhanced neuromuscular blockade
ADMINISTRATION
Reconstition
–
Route
Oral, IV, IM
Rate of Administration
10–60 minutes
Comments
Dilute prior to IV administration: up to 900 mg, in at least 50 mL of diluent; over 900 mg, in 100 mL of diluent. Compatible with sodium chloride 0.9% or glucose 5%Administration of more than 1200 mg in a single 1 hour infusion is not recommendedDoses greater than 600 mg should be given as IV infusions
OTHER INFORMATION
Capsules should be swallowed whole with a glass of waterPseudomembranous colitis may occur Periodic kidney and liver function tests should be carried out during prolonged therapyDosage may require reduction in patients with severe renal impairment due to prolonged half-life